Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Sep 02, 2022 10:41am
139 Views
Post# 34937968

RE:Ir

RE:Ir THTX = 16 shares traded so far this morning and holding at a near 52 week low.  I would love to sit down with Phillipe and ask him exactly why this is acceptable under any circumstances and what the plan other than burry the head in the sand and wait to see strategy is...not will be.  I sent an email asking the question and received no response.

Bucknelly21 wrote: Si i have been following ir at cybin since leag gibson left thera, its pretty apparent that she was not the issue with what was said and what was not, i have to think that since ir most likely reports to phillipe that these ir announcements are up to him which explains alot. Cybin is up almost 100% in the past few months and they post to various platforms every day. I do find the new ir person to be a little odd with some of the things she has said but whoever is in that position seems to be somewhat hamstrung by phillipe in my opinion 


<< Previous
Bullboard Posts
Next >>